ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,398 | -35.1% | 14,776 | 0.0% | 0.00% | – |
| Q1 2023 | $5,237 | -2.7% | 14,776 | -11.9% | 0.00% | – |
| Q4 2022 | $5,383 | -55.1% | 16,776 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | -20.0% | 16,776 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -40.0% | 16,776 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -55.4% | 16,776 | +6.5% | 0.00% | – |
| Q3 2021 | $56,000 | – | 15,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |